Island Pharmaceuticals Ltd
ASX:ILA

Watchlist Manager
Island Pharmaceuticals Ltd Logo
Island Pharmaceuticals Ltd
ASX:ILA
Watchlist
Price: 0.43 AUD Market Closed
Market Cap: AU$115.7m

Operating Margin

-6 626.2%
Current
Improving
by 66 598.3%
vs 3-y average of -73 224.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6 626.2%
=
Operating Income
AU$-3.9m
/
Revenue
AU$58.8k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-6 626.2%
=
Operating Income
AU$-3.9m
/
Revenue
AU$58.8k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Island Pharmaceuticals Ltd
ASX:ILA
115.7m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Lower than 90% of companies in Australia
Percentile
10th
Based on 3 951 companies
10th percentile
-6 626.2%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Island Pharmaceuticals Ltd
Glance View

Market Cap
115.7m AUD
Industry
Pharmaceuticals

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm focuses on developing preventative or therapeutic drugs for viral infections. Its lead product candidate ISLA-101, is a drug developed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Its ISLA-101 is an antiviral oral drug to treat mosquito-borne viruses and is in Phase II of the clinical program.

ILA Intrinsic Value
0.01 AUD
Overvaluation 99%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-6 626.2%
=
Operating Income
AU$-3.9m
/
Revenue
AU$58.8k
What is Island Pharmaceuticals Ltd's current Operating Margin?

The current Operating Margin for Island Pharmaceuticals Ltd is -6 626.2%, which is above its 3-year median of -73 224.5%.

How has Operating Margin changed over time?

Over the last 3 years, Island Pharmaceuticals Ltd’s Operating Margin has increased from -76 237% to -6 626.2%. During this period, it reached a low of -245 930.8% on Dec 31, 2024 and a high of -6 626.2% on Jul 30, 2025.

Back to Top